CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies...
Initial Shipment of 100,000+ Meal Replacement Bars Scheduled to Leave Miami to Help Those in Need in War-Torn Country of...
ATLANTA, GA, March 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Springs Rejuvenation Inc. (OTC Pink: SPRJ) is pleased to provide...
SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating...
Simon Kindleysides is first paralyzed man to climb a 51-story skyscraper; earns his second Guinness World Record using his ReWalk...
Joins multiple companion animals and a horse successfully treated with SRTBOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) --...
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat”MIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) --...
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
NEW ORLEANS and LONDON, March 24, 2022 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe Camsirubicin Phase 1b Dose-Esclation Trial Clears 2nd...
New interim data from TACTI-002 (Part B) evaluating the combination of efti and pembrolizumab in 2nd line, confirmed PD-1/PD-L1 refractory,...
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the...
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, neuro-focused...
Piezo Motion partnership with MEV Elektronik will deliver motion control and automation solutions to original equipment manufacturers in central and...
WARSAW, Ind., March 24, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Health Canada approval continues Sientra’s international expansion and growth accelerationSANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc....
Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task forceMIAMI, March 24, 2022 (GLOBE NEWSWIRE)...
Trudhesa™ Exceeds Fourth Quarter 2021 Prescription Guidance; Strong Launch Continues Into 2022 Demonstrated by 157% Growth Since December 31, 2021...
SUNNYVALE, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the...
On Track to Initiate Phase 1 Clinical Trials in Healthy Volunteers for SZN-1326 and SZN-043 in the Third Quarter of...
